483 AMAG Pharmaceuticals May 2012

483 AMAG Pharmaceuticals May 2012

$119 - Not in Stock

FDA investigators audited the AMAG Pharmaceuticals - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 24 May 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2012
  • Location: Cambridge, United States
  • FEI: 1220373
Order